124 related articles for article (PubMed ID: 31568898)
1. Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study.
Osmani F; Hajizadeh E; Rasekhi A; Akbari ME
Breast; 2019 Dec; 48():82-88. PubMed ID: 31568898
[TBL] [Abstract][Full Text] [Related]
2. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
[TBL] [Abstract][Full Text] [Related]
4. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort.
Lafourcade A; His M; Baglietto L; Boutron-Ruault MC; Dossus L; Rondeau V
BMC Cancer; 2018 Feb; 18(1):171. PubMed ID: 29426294
[TBL] [Abstract][Full Text] [Related]
6. Association between Multiple Recurrent Events with Multivariate Modeling: A Retrospective Cohort Study.
Osmani F; Hajizadeh E; Rasekhi A
J Res Health Sci; 2018 Dec; 18(4):e00433. PubMed ID: 30728319
[TBL] [Abstract][Full Text] [Related]
7. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
8. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.
Veronesi U; Marubini E; Del Vecchio M; Manzari A; Andreola S; Greco M; Luini A; Merson M; Saccozzi R; Rilke F
J Natl Cancer Inst; 1995 Jan; 87(1):19-27. PubMed ID: 7666458
[TBL] [Abstract][Full Text] [Related]
9. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
10. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.
Haffty BG; Reiss M; Beinfield M; Fischer D; Ward B; McKhann C
J Clin Oncol; 1996 Jan; 14(1):52-7. PubMed ID: 8558220
[TBL] [Abstract][Full Text] [Related]
11. [Breast cancer relative survival after the first recurrence and related prognostic factors].
Sarasqueta C; Martínez-Camblor P; Mendiola A; Martínez-Pueyo I; Michelena MJ; Basterretxea M; Recio J; Alvarez I; Larrañaga N
Med Clin (Barc); 2009 Oct; 133(13):489-95. PubMed ID: 19632693
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
13. Local-regional breast cancer recurrence: prognostic groups based on patterns of failure.
Moran MS; Haffty BG
Breast J; 2002; 8(2):81-7. PubMed ID: 11896752
[TBL] [Abstract][Full Text] [Related]
14. Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990-2011.
Malmgren J; Hurlbert M; Atwood M; Kaplan HG
Breast Cancer Res Treat; 2019 Apr; 174(2):505-514. PubMed ID: 30560462
[TBL] [Abstract][Full Text] [Related]
15. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
16. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
17. Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases.
Akbari ME; Rohani- Rasaf M; Nafissi N; Akbari A; Shojaee L
Asian Pac J Cancer Prev; 2018 Apr; 19(4):949-953. PubMed ID: 29693352
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments.
Yu JI; Park W; Choi DH; Huh SJ; Nam SJ; Kim SW; Lee JE; Kil WH; Im YH; Ahn JS; Park YH; Cho EY
Clin Breast Cancer; 2015 Dec; 15(6):512-8. PubMed ID: 26188791
[TBL] [Abstract][Full Text] [Related]
19. Recurrence and death from breast cancer after complete treatments: an experience from hospitals in Northern Thailand.
Chairat R; Puttisri A; Pamarapa A; Wongrach N; Tawichasri C; Patumanond J; Tantraworasin A; Charoentum C
J Med Assoc Thai; 2014 Sep; 97(9):932-8. PubMed ID: 25536710
[TBL] [Abstract][Full Text] [Related]
20. Application of a Non-Mixture Cure Rate Model for Analyzing Survival of Patients with Breast Cancer.
Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
Asian Pac J Cancer Prev; 2015; 16(16):7359-63. PubMed ID: 26514537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
